Literature DB >> 31388278

Detection of BCR/PDGRFα Fusion Using Dual Colour Dual Fusion BCR/ABL1 Probe: An Illustrative Report.

Manish Kumar Singh1, Arun Sasikumaran Nair Remani1, Saurabh Jayant Bhave2, Deppak Kumar Mishra3, Neeraj Arora3, Mayur Parihar4.   

Abstract

Entities:  

Year:  2019        PMID： 31388278      PMCID： PMC6646510          DOI： 10.1007/s12288-019-01095-9

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN： 0971-4502            Impact factor:   0.900


× No keyword cloud information.
  8 in total

1.  t(4;22)(q12;q11.2) involving presumptive platelet-derived growth factor receptor A and break cluster region in a patient with mixed phenotype acute leukemia.

Authors:  Huan-You Wang; John A Thorson; H Elizabeth Broome; Hooman H Rashidi; Peter T Curtin; Marie L Dell'Aquila
Journal:  Hum Pathol       Date:  2011-06-14       Impact factor: 3.466

2.  BCR-PDGFRA fusion in a T lymphoblastic leukemia/lymphoma.

Authors:  Nuri Yigit; William W Wu; Shivakumar Subramaniyam; Susan Mathew; Julia T Geyer
Journal:  Cancer Genet       Date:  2015-04-28

3.  The t(4;22)(q12;q11) in atypical chronic myeloid leukaemia fuses BCR to PDGFRA.

Authors:  E Joanna Baxter; Andreas Hochhaus; Pascual Bolufer; Andreas Reiter; José M Fernandez; Leonor Senent; José Cervera; Federico Moscardo; Miguel A Sanz; Nicholas C P Cross
Journal:  Hum Mol Genet       Date:  2002-06-01       Impact factor: 6.150

Review 4.  Myeloid neoplasms with eosinophilia.

Authors:  Andreas Reiter; Jason Gotlib
Journal:  Blood       Date:  2016-12-27       Impact factor: 22.113

Review 5.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

6.  Chronic myeloproliferative disorders with rearrangement of the platelet-derived growth factor alpha receptor: a new clinical target for STI571/Glivec.

Authors:  Pascal Trempat; Claire Villalva; Guy Laurent; Florence Armstrong; Georges Delsol; Nicole Dastugue; Pierre Brousset
Journal:  Oncogene       Date:  2003-08-28       Impact factor: 9.867

7.  Molecular and cytogenetic characterization of a novel translocation t(4;22) involving the breakpoint cluster region and platelet-derived growth factor receptor-alpha genes in a patient with atypical chronic myeloid leukemia.

Authors:  Anne Michele Safley; Siby Sebastian; Timothy S Collins; Carlos A Tirado; Timothy T Stenzel; Jerald Z Gong; Barbara K Goodman
Journal:  Genes Chromosomes Cancer       Date:  2004-05       Impact factor: 5.006

8.  Screening for diverse PDGFRA or PDGFRB fusion genes is facilitated by generic quantitative reverse transcriptase polymerase chain reaction analysis.

Authors:  Philipp Erben; Darko Gosenca; Martin C Müller; Jelena Reinhard; Joannah Score; Francesco Del Valle; Christoph Walz; Jürgen Mix; Georgia Metzgeroth; Thomas Ernst; Claudia Haferlach; Nicholas C P Cross; Andreas Hochhaus; Andreas Reiter
Journal:  Haematologica       Date:  2010-01-27       Impact factor: 9.941
  8 in total
  1 in total

Review 1.  A rare cause of persistent leukocytosis with massive splenomegaly: Myeloid neoplasm with BCR-PDGFRA rearrangement-Case report and literature review.

Authors:  Lu Gao; Yan Xu; Lan-Chun Weng; Zu-Guo Tian
Journal:  Medicine (Baltimore)       Date:  2022-06-17       Impact factor: 1.817
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.